BIRC3 and glioblastoma: To test if BIRC3 was necessary for hypoxia-induced resistance to RT, U87 GBM cells were treated with BIRC3-specific siRNA, which significantly impaired BIRC3 mRNA and protein levels in cells exposed to hypoxia conditions versus control siRNA treated cells (Fig. 7A,B; p < 0.05).